ELP1 and malaria: We therefore, intended in this study to assess and compare the prevalence of fd-D193Y, aps10-V127M, pfmdr2-T484I, crt-I356T, crt-N326S and K13 mutations in P. falciparum parasites before (2005) and after- (2013) introduction of artemisinin-based combination therapies for malaria treatment in Uganda [18].